药物分子与靶蛋白相互作用的研究进展

李安; 周小青; 孙阔; 杨谨如; 朱勇飞; 陆一鸣

doi:10.3969/j.issn.1006-0111.2019.01.001

药物分子与靶蛋白相互作用的研究进展

doi: 10.3969/j.issn.1006-0111.2019.01.001

1.
海军军医大学药学院, 上海 200433
2.
湖南师范大学医学院, 湖南长沙 410013

基金项目: 国家自然科学基金（81773627）；国家重点研发计划（2018YFC0310900）；上海市科委"科技创新行动计划"生物医药领域科技支撑项目（16431904400）

Research advance on the interaction of pharmaceutical molecules with target proteins

1.
School of Pharmacy, Naval Medical University, Shanghai 200433, China
2.
School of Medicine, Hunan Normal University, Changsha 410013, China

摘要: 药物发挥作用是以药物分子与其靶标的相互作用为基础的，对药物-靶点相互作用的定性分析与定量检测贯穿于从新药筛选发现到走向临床的整个过程。经过几十年的发展，研究药物分子与靶蛋白间相互作用的手段已经从传统的生化实验方法转变为以先进的分子生物学、生物物理学理论为支撑的高效、准确、多样化的技术体系。笔者从靶点发现与验证、亲和力测定、相互作用位点与结构分析几个方面对代表性的方法和技术进行介绍，以期为药物研发与机制探索提供参考。
- 相互作用 /
- 靶蛋白 /
- 药物筛选 /
- 亲和力 /
- 结合位点
Abstract: The function of drugs is based on the interaction between drug molecules and their targets.Qualitative analysis and quantitative detection of drug-target interactions run through the whole process from drug discovery to clinical practice.After decades of development, the study methods on the interaction between drug molecules and target proteins have been transformed from traditional biochemical experiments to a diversity of efficient and accurate technology systems supported by advanced molecular biology and biophysics theory.In this review, representative methods and techniques were introduced from aspects of target discovery and validation, affinity determination, interaction sites and structural analysis, which might provide some references for drug discovery and mechanism exploration.
- interaction /
- target protein /
- drug screening /
- affinity /
- binding sites

[1]	MARTINEZ MOLINA D,JAFARI R,IGNATUSHCHENKO M,et al.Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay[J].Science,2013,341(6141):84-87.
[2]	SHAW J,LEVERIDGE M,NORLING C,et al.Determining direct binders of the androgen receptor using a high-throughput cellular thermal shift assay[J].Sci Rep,2018,8(1):163.
[3]	ROUX K J,KIM D I,BURKE B,et al.BioID:a screen for protein-protein interactions[J].Curr Protoc in Protein Sci,2018,91:1-15.
[4]	ZHUANG M,GUAN S,WANG H,et al.Substrates of IAP ubiquitin ligases identified with a designed orthogonal E3 ligase,the NEDDylator[J].Mol Cell,2013,49(2):273-282.
[5]	HILL Z B,POLLOCK S B,ZHUANG M,et al.Direct proximity tagging of small molecule protein targets using an engineered NEDD8 ligase[J].J Am Chem Soc,2016,138(40):13123-13126.
[6]	LINKUVIENÉ V,TALIBOV V O,DANIELSON U H,et al.Introduction of intrinsic kinetics of protein-ligand interactions and their implications for drug design[J].J Med Chem,2018,61(6):2292-2302.
[7]	POLONSCHⅡ C,DAVID S,GáSPáR S,et al.Complementarity of EIS and SPR to reveal specific and nonspecific binding when interrogating a model bioaffinity sensor; perspective offered by plasmonic based EIS[J].Anal Chem,2014,86(17):8553-8562.
[8]	HALPERN A R,WOOD J B,WANG Y,et al.Single-nanoparticle near-infrared surface plasmon resonance microscopy for real-time measurements of DNA hybridization adsorption[J].ACS Nano,2013,8(1):1022-1030.
[9]	WANG S,SHAN X,PATEL U,et al.Label-free imaging,detection,and mass measurement of single viruses by surface plasmon resonance[J].Proc Natl Acad Sci USA,2010,107(37):16028-16032.
[10]	SYAL K,WANG W,SHAN X,et al.Plasmonic imaging of protein interactions with single bacterial cells[J].Biosens Bioelectron,2015,63:131-137.
[11]	WELSCH M E,KAPLAN A,CHAMBERS J M,et al.Multivalent small-molecule pan-RAS inhibitors[J].Cell,2017,168(5):878-889.e29.
[12]	DI TRANI J M,DE CESCO S,O'LEARY R,et al.Rapid measurement of inhibitor binding kinetics by isothermal titration calorimetry[J].Nat Commun,2018,9(1):893.
[13]	WIENKEN C J,BAASKE P,ROTHBAUER U,et al.Protein-binding assays in biological liquids using microscale thermophoresis[J].Nat Commun,2010,1(7):100.
[14]	PARKER J L,NEWSTEAD S.Molecular basis of nitrate uptake by the plant nitrate transporter NRT1.1[J].Nature,2014,507(7490):68-72.
[15]	SEIDEL S A,DIJKMAN P M,LEA W A,et al.Microscale thermophoresis quantifies biomolecular interactions under previously challenging conditions[J].Methods,2013,59(3):301-315.
[16]	JERABEK-WILLEMSEN M,WIENKEN C J,BRAUN D,et al.Molecular interaction studies using microscale thermophoresis[J].Assay Drug Dev Technol,2011,9(4):342-353.
[17]	WANG J,LI H,HAN Z,et al.Allosteric receptor activation by the plant peptide hormone phytosulfokine[J].Nature,2015,525(7568):265-268.
[18]	SCHIEBEL J, RADEVA N, KÖSTER H,et al.One question,multiple answers:Biochemical and biophysical screening methods retrieve deviating fragment hit lists[J].ChemMedChem,2015,10(9):1511-1521.
[19]	BLUNDELL T L,PATEL S.High-throughput X-ray crystallography for drug discovery[J].Curr Opin Pharmacol,2004,4(5):490-496.
[20]	HUBBARD R E,MURRAY J B.Experiences in fragment-based lead discovery[J].Meth Enzymol,2011,493:509-531.
[21]	CALA O,GUILLIERE F,KRIMM I.NMR-based analysis of protein-ligand interactions[J].Anal Bioanal Chem,2014,406:943-956.
[22]	PELLECCHIA M,BERTINI I,COWBURN D,et al.Perspectives on NMR in drug discovery:a technique comes of age[J].Nat Rev Drug Discov,2008,7:738-745.
[23]	HARNER M J,FRANK A O,FESIK S W.Fragment-based drug discovery using NMR spectroscopy[J].J Biomol NMR,2013,56:65-75.
[24]	WU B,BARILE E,DE S K,et al.High-throughput screening by nuclear magnetic resonance (HTS by NMR) for the identification of PPIs antagonists[J].Curr Top Med Chem,2015,15:2032-2042.
[25]	VESTERGAARD B,SAYERS Z.Investigating increasingly complex macromolecular systems with small-angle X-ray scattering[J].IUCrJ,2014,1(Pt 6):523-529.
[26]	TUUKKANEN A T,SVERGUN D I.Weak protein-ligand interactions studied by small-angle X-ray scattering[J].FEBS J,2014,281(8):1974-1987.
[27]	NAGATOISHI S,YAMAGUCHI S,KATOH E,et al.A combination of 19F NMR and surface plasmon resonance for site-specific hit selection and validation of fragment molecules that bind to the ATP-binding site of a kinase[J].Bioorg Med Chem,2018,26(8):1929-1938.
[28]	YAN C,LIU D,LI L,et al.Discovery and characterization of small molecules that target the GTPase Ral[J].Nature,2014,515(7527):443-447.
[29]	RENAUD J P,CHUNG C W,DANIELSON U H,et al.Biophysics in drug discovery:impact,challenges and opportunities[J].Nat Rev Drug Discov,2016,15(10):679-698.

[1]	关梦瑶, 夏天爽, 何旭辉, 史策, 蒋益萍, 辛海量. 黑蒜多糖抗便秘作用研究 . 药学实践与服务, 2025, 43(4): 190-194. doi: 10.12206/j.issn.2097-2024.202403059
[2]	王新霞, 刘祉君, 吕磊, 张爽, 高守红. 鬼针草降压作用研究及展望 . 药学实践与服务, 2025, 43(): 1-4. doi: 10.12206/j.issn.2097-2024.202408021
[3]	李锐, 张倩倩, 王瑞冬, 高小峰. 国家集中带量采购政策下样本医院良性前列腺增生治疗药物使用情况分析 . 药学实践与服务, 2025, 43(1): 41-46. doi: 10.12206/j.issn.2097-2024.202408031
[4]	闻韬, 焦广洋, 赵梦沛, 岳小强, 张凤, 陈万生. 基于UHPLC-Q-TOF/MS结合网络药理学研究柴胡桂枝干姜汤治疗慢性非萎缩性胃炎的物质基础及疗效机制 . 药学实践与服务, 2025, 43(): 1-9. doi: 10.12206/j.issn.2097-2024.202312061
[5]	张岩, 李炎君, 刘家荟, 邓娇, 原苑, 张敬一. 药物性肝损伤不良反应分析 . 药学实践与服务, 2025, 43(1): 26-29, 40. doi: 10.12206/j.issn.2097-2024.202404034
[6]	詹济华, 颜滢. 低蛋白血症对头孢哌酮血药浓度的影响 . 药学实践与服务, 2025, 43(): 1-5. doi: 10.12206/j.issn.2097-2024.202309040
[7]	魏莱, 董国强, 盛春泉. 靶向SARS-CoV-2主蛋白酶的PROTAC设计、合成与蛋白降解活性研究 . 药学实践与服务, 2025, 43(5): 1-8. doi: 10.12206/j.issn.2097-2024.202503063
[8]	冯婷婷, 张景翔, 王彦, 许维恒, 张俊平. ANXA3基因及蛋白的研究进展 . 药学实践与服务, 2025, 43(2): 47-50, 74. doi: 10.12206/j.issn.2097-2024.202309023
[9]	张修平, 田家盛, 王道鑫, 李佳鑫, 王品, 缪朝玉. MT-1207对小鼠血糖、血脂和动脉粥样硬化的作用 . 药学实践与服务, 2024, 42(11): 487-494. doi: 10.12206/j.issn.2097-2024.202306011
[10]	李清, 郭宜银, 陈颖, 瞿发林, 董文燊, 戈煜. 夜宁胶囊对小鼠镇静催眠作用及其机制的研究 . 药学实践与服务, 2024, 42(8): 346-349. doi: 10.12206/j.issn.2097-2024.202211047
[11]	张林晨, 张小琴, 张俊平. 山楂酸药理作用的研究进展 . 药学实践与服务, 2024, 42(5): 185-189. doi: 10.12206/j.issn.2097-2024.202307052
[12]	宋雨桐, 夏德润, 顾珩, 唐少文, 易洪刚, 沃红梅. 帕博利珠单抗与铂类化疗方案在晚期非小细胞肺癌一线治疗中的药物经济学评价 . 药学实践与服务, 2024, 42(8): 334-340. doi: 10.12206/j.issn.2097-2024.202303023
[13]	张艺昕, 关欣怡, 王博宁, 闻俊, 洪战英. 二氢吡啶类钙离子拮抗药物手性分析及其立体选择性药动学研究进展 . 药学实践与服务, 2024, 42(8): 319-324. doi: 10.12206/j.issn.2097-2024.202308062
[14]	何亚伦, 祁智, 常杰. 消胀通便膏在晚期肝癌患者阿片类药物相关性便秘中的应用研究 . 药学实践与服务, 2024, 42(12): 520-523. doi: 10.12206/j.issn.2097-2024.202309009
[15]	夏哲炜, 曾垣烨, 朱海菲, 李育, 陈啸飞. 核磁共振磷谱法测定磷酸氢钙咀嚼片中药物含量 . 药学实践与服务, 2024, 42(9): 399-401, 406. doi: 10.12206/j.issn.2097-2024.202404063
[16]	孙丹倪, 黄勇, 张嘉宝, 王培. 代谢相关脂肪性肝病的无创诊断与药物治疗 . 药学实践与服务, 2024, 42(10): 411-418. doi: 10.12206/j.issn.2097-2024.202403049
[17]	陈怡君, 王卓, 何苗, 张宇, 田泾. 泌尿系统碎石术抗菌药物预防使用合理管控实践 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202402034
[18]	张元林, 宋凯, 孙蕊, 舒飞, 舒丽芯, 杨樟卫. 基于真实世界数据的药物利用研究综述 . 药学实践与服务, 2024, 42(6): 238-243. doi: 10.12206/j.issn.2097-2024.202312010
[19]	刘汝雄, 杨万镇, 涂杰, 盛春泉. 铁死亡调控蛋白GPX4的小分子抑制剂研究进展 . 药学实践与服务, 2024, 42(9): 375-378. doi: 10.12206/j.issn.2097-2024.202312075
[20]	白学鑫, 陈玉平, 盛春泉, 武善超. 具核梭杆菌小分子抑制剂的筛选及其抗结直肠癌活性研究 . 药学实践与服务, 2024, 42(12): 503-507. doi: 10.12206/j.issn.2097-2024.202405009

点击查看大图

计量

文章访问数: 8629
HTML全文浏览量: 2066
PDF下载量: 715
被引次数: 0

姓名
邮箱
手机号码
标题
留言内容
验证码

留言板

药物分子与靶蛋白相互作用的研究进展

doi: 10.3969/j.issn.1006-0111.2019.01.001

Research advance on the interaction of pharmaceutical molecules with target proteins

计量

药物分子与靶蛋白相互作用的研究进展

doi: 10.3969/j.issn.1006-0111.2019.01.001

1. 海军军医大学药学院, 上海 200433

2. 湖南师范大学医学院, 湖南长沙 410013

English Abstract

Research advance on the interaction of pharmaceutical molecules with target proteins

1. School of Pharmacy, Naval Medical University, Shanghai 200433, China

2. School of Medicine, Hunan Normal University, Changsha 410013, China

全文HTML

目录

留言板

药物分子与靶蛋白相互作用的研究进展

doi: 10.3969/j.issn.1006-0111.2019.01.001

Research advance on the interaction of pharmaceutical molecules with target proteins

计量

出版历程

药物分子与靶蛋白相互作用的研究进展

doi: 10.3969/j.issn.1006-0111.2019.01.001

1. 海军军医大学药学院, 上海 200433 2. 湖南师范大学医学院, 湖南 长沙 410013

English Abstract

Research advance on the interaction of pharmaceutical molecules with target proteins

1. School of Pharmacy, Naval Medical University, Shanghai 200433, China 2. School of Medicine, Hunan Normal University, Changsha 410013, China

全文HTML

目录

1. 海军军医大学药学院, 上海 200433

2. 湖南师范大学医学院, 湖南长沙 410013

1. School of Pharmacy, Naval Medical University, Shanghai 200433, China

2. School of Medicine, Hunan Normal University, Changsha 410013, China